Background: Little is known about advance directive (AD) utilization in implantable cardioverter-defibrillator (ICD) recipients.
Objective: The purpose of this study was to define the prevalence and predictors of ADs in patients with ICDs.
Methods: We identified ICD recipients with ADs at our institution.
Aims: End-stage renal disease (ESRD) increases the risk of implantable cardioverter-defibrillator (ICD) infection. We sought to define outcomes of lead extraction in patients with ESRD.
Methods And Results: Implantable cardioverter-defibrillator lead extractions at our institution from January 2006 to March 2014 were stratified by absence (Control-Ex, n = 465) or presence (ESRD-Ex, n = 43) of ESRD.